Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2026-02-20 @ 8:15 PM
Study NCT ID:
NCT03312335
Status:
COMPLETED
Last Update Posted:
2020-08-19
First Post:
2017-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus
Sponsor:
Onur Boyman, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
USZ-IM-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None